# Walter Stockinger

> Walter Stockinger is a Series A investor at Hadean Ventures backing Biotechnology and Health Care. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Hadean Ventures](https://shizune.co/investors/profile/hadean-ventures)
- Location: Ebenfurth, Austria
- Total investments: 5
- Last investment: Oct 2025
- Lead investor: 80%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/walter-stockinger-dr-13b1a4b/

Walter Stockinger is a Series A investor at Hadean Ventures in Ebenfurth focused on Biotechnology and Health Care. Walter Stockinger is based out of Ebenfurth, Niederösterreich, and is the managing partner of Hadean Ventures. Walter previously worked at Inventages Venture Capital as a board member and board observer. Walter Stockinger attended the University of Vienna.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 80% |
| Health Care | 1 | 20% |
| Pharmaceutical | 1 | 20% |
| Clinical Trials | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 40% |
| Series B | 1 | 20% |
| Series C | 1 | 20% |
| Series D | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Austria | 3 | 60% |
| France | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Step Pharma | Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe. | $44.3M | Series C | Oct 15, 2025 |  |
| Ribbon Biolabs | Ribbon Biolabs defines new standards for molecular biology by applying innovative methods for DNA synthesis. | $19.7M | Series A | Jan 31, 2022 |  |
| Ribbon Bio | Ribbon Biolabs defines new standards for molecular biology by applying innovative methods for DNA synthesis. | $20.2M | Series A | Jan 31, 2022 |  |
| Step Pharma | Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe. | $41.3M | Series B | Mar 24, 2021 |  |
| Themis Bioscience | Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing andacquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies. | $43.9M | Series D | Sep 18, 2019 |  |

5 of 5 investments shown.

## Co-investors
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 2 deals together
- [Kurma Partners](https://shizune.co/investors/profile/kurma-life-science-partners) — VC Fund, 2 deals together
- [Lansdowne Partners](https://shizune.co/investors/profile/lansdowne-partners) — VC Fund, 2 deals together
- [Pontifax](https://shizune.co/investors/profile/pontifax) — VC Fund, 2 deals together
- [Sunstone Life Science Ventures](https://shizune.co/investors/profile/sunstone-capital-life-science) — VC Fund, 2 deals together
- [tecnet equity](https://shizune.co/investors/profile/tecnet-equity) — VC Fund, 2 deals together

## About Hadean Ventures

VC Fund · Oslo, Norway

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion

5 contacts available at Hadean Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Florian Eckhardt | Senior Investment Director | https://shizune.co/investors/profile/florian-eckhardt |
| Ingrid Akay | Founder and Managing Partner | https://shizune.co/investors/profile/ingrid-teigland-akay |
| Ingrid Beyer | Head of Investor Relations | https://shizune.co/investors/profile/ingrid-beyer |
| Roger Franklin | Partner | https://shizune.co/investors/profile/roger-franklin-fbab |
| Walter Stockinger | Managing Partner | https://shizune.co/investors/profile/walter-stockinger |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Walter Stockinger invest in?

Walter Stockinger invests primarily in Biotechnology, Health Care and Pharmaceutical startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Walter Stockinger last invest?

The most recent investment recorded for Walter Stockinger closed in Oct 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co